Mesco Pharmaceuticals Ltd.
| BSE: 500274 | Sector: Health care |
| NSE: MESCOPHARM | ISIN Code: INE839X01015 |
| BSE 00:00 | 27 Jan | Mesco Pharmaceuticals Ltd |
| NSE 05:30 | 01 Jan | Mesco Pharmaceuticals Ltd |
| OPEN | 7.25 |
| PREVIOUS CLOSE | 7.25 |
| VOLUME | 100 |
| 52-Week high | 8.68 |
| 52-Week low | 7.25 |
| P/E | |
| Mkt Cap.(Rs cr) | 15 |
| Buy Price | 7.25 |
| Buy Qty | 200.00 |
| Sell Price | 7.25 |
| Sell Qty | 400.00 |
Mesco Pharmaceuticals Ltd. (MESCOPHARM) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 881.35 | -5.40 | -0.61 | 13266.48 |
| Cipla | 813.55 | 1.45 | 0.18 | 12659.15 |
| Sun Pharma.Inds. | 620.95 | 6.55 | 1.07 | 12531.93 |
| Dr Reddy's Labs | 4445.95 | 39.75 | 0.90 | 11850.40 |
| Lupin | 1057.55 | 2.95 | 0.28 | 11025.66 |
| Apollo Hospitals | 3069.70 | -20.05 | -0.65 | 9794.50 |
| Glenmark Pharma. | 476.90 | 0.70 | 0.15 | 6712.63 |
| Alkem Lab | 2859.00 | -51.15 | -1.76 | 6677.08 |
| Cadila Health. | 445.35 | 4.40 | 1.00 | 6347.40 |
| Torrent Pharma. | 2472.25 | 3.30 | 0.13 | 6168.44 |
| Divi's Lab. | 3538.05 | 22.50 | 0.64 | 5310.57 |
| Ipca Labs. | 1921.80 | 15.65 | 0.82 | 4337.82 |
| Piramal Enterp. | 1986.45 | 68.45 | 3.57 | 4219.19 |
| Alembic Pharma | 932.25 | -2.80 | -0.30 | 4132.55 |
| Abbott India | 14644.15 | 121.95 | 0.84 | 4093.14 |
| Glaxosmi. Pharma | 1505.85 | 38.75 | 2.64 | 3224.68 |
| Jubilant Pharmo | 774.25 | -5.85 | -0.75 | 3139.90 |
| Sanofi India | 8342.05 | 15.50 | 0.19 | 3070.60 |
| Laurus Labs | 365.85 | 3.80 | 1.05 | 2797.34 |
| Gland Pharma | 2417.95 | 68.00 | 2.89 | 2633.24 |
Quick Links for Mesco Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
